The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines
- PMID: 17881401
- DOI: 10.1177/1352458506075651
The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines
Abstract
Vesicourethral dysfunction is very frequent in multiple sclerosis (MS) and has functional consequences for patients' quality of life and also an organic impact following complications of the neurogenic bladder on the upper urinary tract. While the functional impact and its management are well documented in the literature, the organic impact remains underestimated and there are no consensual practical guidelines for the screening and prevention of MS neurogenic bladder complications. The aim of this review of the literature, focused on identifying the risk factors of urinary tract complications in MS, is to put forward well informed considerations to help in the definition of practical guidelines for the follow-up of the neurogenic bladder in MS in order to improve its prevention and patient management. Four main risk factors have been identified for upper urinary tract damage: the duration of MS, the presence of an indwelling catheter, high-amplitude neurogenic detrusor contractions and permanent high detrusor pressure. Detrusor-sphincter dyssynergia, age over 50 and male sex may form three additional risk factors. Recommendations for long-term urological follow-up, taking into account these specific risks are constructed according to the procedures recommended by the French Health Authorities.
Similar articles
-
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients].Ann Readapt Med Phys. 2008 May;51(4):315-21. doi: 10.1016/j.annrmp.2008.03.003. Epub 2008 May 7. Ann Readapt Med Phys. 2008. PMID: 18514963 French.
-
Management of neurogenic bladder patients in The Netherlands: do urologists follow guidelines?Neurourol Urodyn. 2008;27(8):758-62. doi: 10.1002/nau.20582. Neurourol Urodyn. 2008. PMID: 18508332
-
[Genital and sphincter disorders].Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):1051-9. Rev Neurol (Paris). 2001. PMID: 11787336 Review. French.
-
[Guidelines in the treatment of neurogenic bladder].Acta Med Port. 1999 Jan-Mar;12(1-3):119-21. Acta Med Port. 1999. PMID: 10423885 Portuguese.
-
[Management of neuropathic bladder in multiple sclerosis].Clin Ter. 2004 May;155(5):183-6. Clin Ter. 2004. PMID: 15344566 Review. Italian.
Cited by
-
Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review.Int Neurourol J. 2020 Sep;24(3):241-257. doi: 10.5213/inj.2040058.029. Epub 2020 Sep 30. Int Neurourol J. 2020. PMID: 33017895 Free PMC article.
-
Management of bladder dysfunction in multiple sclerosis: a systematic review and meta-analysis of studies regarding bladder rehabilitation.Eur J Phys Rehabil Med. 2022 Jun;58(3):387-396. doi: 10.23736/S1973-9087.22.07217-3. Epub 2022 Feb 1. Eur J Phys Rehabil Med. 2022. PMID: 35102733 Free PMC article.
-
Invasive Therapies in Multiple Sclerosis.Noro Psikiyatr Ars. 2018;55(Suppl 1):S21-S25. doi: 10.29399/npa.23362. Noro Psikiyatr Ars. 2018. PMID: 30692850 Free PMC article. Review.
-
Latissimus dorsi detrusor myoplasty for bladder acontractility: a systematic review.Arch Plast Surg. 2021 Sep;48(5):528-533. doi: 10.5999/aps.2021.00402. Epub 2021 Sep 15. Arch Plast Surg. 2021. PMID: 34583440 Free PMC article.
-
Multiple sclerosis and lower urinary tract symptoms: A survey of prevalence, characteristic and urological evaluations.SAGE Open Med. 2023 Jun 25;11:20503121231178047. doi: 10.1177/20503121231178047. eCollection 2023. SAGE Open Med. 2023. PMID: 37384196 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical